A Blueprint for Enhancing the Security of the U.S. Pharmaceutical Supply Chain

A closely connected, diverse, high-quality and resilient pharmaceutical supply chain based in the United States and in allied countries is the best means to ensure that U.S. patients and our health care system have access to a secure and consistent supply of critical medicines. The United States already plays an important role in this supply chain, with generic companies providing more than 52,000 jobs at nearly 150 facilities, and manufacturing more than 60 billion doses of prescription medicines annually1 in this country.
1. AAM Member Survey and other sources.